The Library
Effectiveness of antipsychotics used in first-episode psychosis : a naturalistic cohort study
Tools
Whale, Richard, Harris, Michael, Kavanagh, Gail, Wickramasinghe, Vijitha , Jones, Christopher I., Marwaha, Steven, Jethwa, Ketan, Ayadurai, Nirmalan and Thompson, Andrew David (2016) Effectiveness of antipsychotics used in first-episode psychosis : a naturalistic cohort study. BJ Psych Open, 2 (5). pp. 323-329. bjporcpsych002766.. doi:10.1192/bjpo.bp.116.002766 ISSN 2056-4724.
PDF
WRAP_bjporcpsych002766.pdf - Requires a PDF viewer. Available under License ["licenses_description_cc_by_nc_nd_2" not defined]. Download (697Kb) |
Official URL: http://dx.doi.org/10.1192/bjpo.bp.116.002766
Abstract
Background
One year of antipsychotic treatment from symptom remission is recommended following a first episode of psychosis (FEP).
Aims
To investigate the effectiveness of commonly used antipsychotic medications in FEP.
Method
A retrospective cohort study of naturalistic treatment of patients (N=460) accepted by FEP services across seven UK sites. Treatment initiation to all-cause discontinuation determined from case files.
Results
Risk of treatment discontinuation is greatest within 3 months of treatment initiation. Risperidone had longest median survival time. No significant differences were observed in time to discontinuation between commonly used antipsychotics on multivariable Cox regression analysis. Poor adherence and efficacy failure were the most common reasons for discontinuation.
Conclusions
Effectiveness differences appear not to be a current reason for antipsychotic choice in FEP. Adherence strategies and weighing up likely adverse effects should be the clinical focus.
Declaration of interest
R.W., A.T. and S.M. have received research grant, speaker honoraria and conference attendance funding from all companies marketing antipsychotics.
Copyright and usage
© The Royal College of Psychiatrists 2016. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) license.
Item Type: | Journal Article | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Subjects: | R Medicine > RM Therapeutics. Pharmacology | ||||||||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Mental Health and Wellbeing Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||||||
Library of Congress Subject Headings (LCSH): | Risperidone, Antipsychotic drugs, Psychoses -- Treatment | ||||||||||
Journal or Publication Title: | BJ Psych Open | ||||||||||
Publisher: | Royal College of Psychiatrists | ||||||||||
ISSN: | 2056-4724 | ||||||||||
Official Date: | September 2016 | ||||||||||
Dates: |
|
||||||||||
Volume: | 2 | ||||||||||
Number: | 5 | ||||||||||
Page Range: | pp. 323-329 | ||||||||||
Article Number: | bjporcpsych002766. | ||||||||||
DOI: | 10.1192/bjpo.bp.116.002766 | ||||||||||
Status: | Peer Reviewed | ||||||||||
Publication Status: | Published | ||||||||||
Access rights to Published version: | Open Access (Creative Commons) |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |
Downloads
Downloads per month over past year